A S Orlova

ResearcherID Scopus Author ID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2020-2022
Publications (10 Years): 7

Top Topics

Botulinum Toxin

Depressive Symptoms

Top Venues

Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova

Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko

Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury

This page only lists publications with an associated author ORCID identifier.

Publications

D I Lebedeva, E F Turovinina, V G Skorikova, E S Akarachkova, A S Orlova
[The second stage of rehabilitation of post-infectious myelopathy after a new coronavirus infection]. Voprosy kurortologii, fizioterapii, i lechebnoi fizicheskoi kultury 99 (4) (2022)
Y V Malygin, A S Orlova, V L Malygin
[Conceptualization of comorbid anxiety and depressive disorders and approaches to their managing]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 122 (6) (2022)
M A Akulov, V N Shimansky, O R Orlova, V O Zakharov, K V Shevchenko, A A Ogurtsova, A S Orlova
[Higher efficacy of botulinum toxin therapy for hemifacial spasm recurrence after vascular decompression. Case report and literature review]. Zhurnal voprosy neirokhirurgii imeni N. N. Burdenko 86 (2) (2022)
V A Karlov, Pavel Vlasov, A B Kozhokaru, A S Orlova
[The efficacy and tolerability of extended release carbamazepine in adult patients with new-onset epilepsy using epileptiform activity index]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (3) (2021)
Larisa A Burygina, V A Orlov, A V Zhilenkova, D E Makaryan, Angelina N Khannanova, A S Orlova, E S Akarachkova
[Social, demographic and clinical characteristics of female patients with schizophrenia and HIV]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 121 (1) (2021)
A B Kozhokaru, A S Samoilov, V I Shmyrev, Michail G Poluektov, A S Orlova
[Sleep and wake disorders in epilepsy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (9. Vyp. 2) (2020)
V A Karlov, A B Kozhokaru, Pavel Vlasov, T N Pushkar, A S Orlova
[Dynamics of epileptiform activity, efficacy and tolerability of valproic acid in adults and adolescents with newly-diagnosed epilepsy]. Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova 120 (7) (2020)